Singapore markets open in 7 hours 59 minutes

BioSig Technologies, Inc. (BSGM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3135-0.1665 (-11.25%)
As of 12:56PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 16.57M
Enterprise value 16.84M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)604.48
Price/book (mrq)36.58
Enterprise value/revenue 935.41
Enterprise value/EBITDA -0.60

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3-87.97%
S&P500 52-week change 325.01%
52-week high 316.5000
52-week low 30.2620
50-day moving average 30.8136
200-day moving average 33.9837

Share statistics

Avg vol (3-month) 31.2M
Avg vol (10-day) 32.74M
Shares outstanding 511.2M
Implied shares outstanding 611.2M
Float 88.53M
% held by insiders 118.81%
% held by institutions 110.29%
Shares short (28 Mar 2024) 4694.94k
Short ratio (28 Mar 2024) 42.37
Short % of float (28 Mar 2024) 48.90%
Short % of shares outstanding (28 Mar 2024) 47.44%
Shares short (prior month 29 Feb 2024) 4895.01k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Sept 2018
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 302 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-51,391.67%

Management effectiveness

Return on assets (ttm)-603.25%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)18k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-91.10%
Gross profit (ttm)N/A
EBITDA -28.15M
Net income avi to common (ttm)-29.05M
Diluted EPS (ttm)-3.9500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)190k
Total cash per share (mrq)0.02
Total debt (mrq)452k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.12
Book value per share (mrq)-0.33

Cash flow statement

Operating cash flow (ttm)-17.31M
Levered free cash flow (ttm)-7.66M